Top Headlines

Covance shocks analysts with two year IT investment plan

Covance is accelerating IT investment faster and for longer than expected, resulting in 2012 guidance that met analysts’ “worst-case fears”.

News in brief

Jubilant buys Lilly out of early-phase JV

Jubilant Life Sciences has bought US drugmaker Eli Lilly’s stake in the early-stage development focused JV the firms set up in 2008.

Contract manufacturing round-up

Outsourcing-Pharma presents a round-up of the latest headlines within the world of contract manufacturing. Catalent and Patheon have each launched oral dosage partnership news, whilst Frontage and AMPAC have received regulatory go-aheads.

People on the move: outsourcing jobs

Outsourcing-Pharma presents its weekly round-up of the latest changes on the pharmaceutical career ladder, including news from Patheon, Wolfe Laboratories, and Premier Research.

CFS plans to tackle financial management diversity in different countries through expansion

Clinical Financial Services (CFS) has made its first foray into the global market after opening a new office in Edinburgh, Scotland.

Global Industry News

US hits Ranbaxy with injunction to boost manufacturing quality from in-PharmaTechnologist.com

The US has filed a “groundbreaking” injunction against Ranbaxy to force the generic giant to make “fundamental changes” at its plants.

Simplifying taxes would encourage Pharma manufacturing in France, says govt advisory board from in-PharmaTechnologist.com

Simplification of French tax laws would incentivise Pharmas to manufacture drugs in the country according to a government advisory body.

EU could make API suppliers verify starting material sources from in-PharmaTechnologist.com

Europe is considering forcing API manufacturers to verify the source of starting materials as part of GMP revisions.

On your radar